These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9850649

  • 1. Glutathione S-transferase pi immunostaining of cisplatin-resistant ovarian cancer cells in ascites.
    Kase H, Kodama S, Nagai E, Tanaka K.
    Acta Cytol; 1998; 42(6):1397-402. PubMed ID: 9850649
    [Abstract] [Full Text] [Related]

  • 2. [Value of P-glycoprotein and glutathione S-transferase-pi as chemo-resistant indicators in ovarian cancers].
    Zhang F, Qi L, Chen H.
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):313-6. PubMed ID: 11783115
    [Abstract] [Full Text] [Related]

  • 3. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy].
    Li L, Yao D, Chen X.
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):95-7. PubMed ID: 10682429
    [Abstract] [Full Text] [Related]

  • 4. Expression of glutathione S-transferase-pi in human ovarian cancer as an indicator of resistance to chemotherapy.
    Hamada S, Kamada M, Furumoto H, Hirao T, Aono T.
    Gynecol Oncol; 1994 Mar; 52(3):313-9. PubMed ID: 8157188
    [Abstract] [Full Text] [Related]

  • 5. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
    Cheng X, Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Okada M, Terakawa N.
    Cancer; 1997 Feb 01; 79(3):521-7. PubMed ID: 9028363
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S, Jiao JW, Sun KX, Zong ZH, Zhao Y.
    Drug Des Devel Ther; 2015 Feb 01; 9():5225-35. PubMed ID: 26396496
    [Abstract] [Full Text] [Related]

  • 7. [Expression of glutathione S-transferase-pi in operative specimens as marker of chemoresistance in patients with ovarian cancer].
    Huang J, Gu M, Chen C.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug 01; 32(8):458-61. PubMed ID: 9639737
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
    Bai F, Nakanishi Y, Kawasaki M, Takayama K, Yatsunami J, Pei XH, Tsuruta N, Wakamatsu K, Hara N.
    Cancer; 1996 Aug 01; 78(3):416-21. PubMed ID: 8697385
    [Abstract] [Full Text] [Related]

  • 9. Expression of glutathione S-transferase pi (GST-pi) in human malignant ovarian tumors.
    Satoh T, Nishida M, Tsunoda H, Kubo T.
    Eur J Obstet Gynecol Reprod Biol; 2001 Jun 01; 96(2):202-8. PubMed ID: 11384808
    [Abstract] [Full Text] [Related]

  • 10. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
    van der Zee AG, Hollema H, Suurmeijer AJ, Krans M, Sluiter WJ, Willemse PH, Aalders JG, de Vries EG.
    J Clin Oncol; 1995 Jan 01; 13(1):70-8. PubMed ID: 7799045
    [Abstract] [Full Text] [Related]

  • 11. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
    Unsal M, Akpolat I, Kandemir B.
    Saudi Med J; 2003 May 01; 24(5):493-8. PubMed ID: 12847624
    [Abstract] [Full Text] [Related]

  • 12. Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients.
    Surowiak P, Materna V, Kaplenko I, Spaczyński M, Dietel M, Lage H, Zabel M.
    Virchows Arch; 2005 Sep 01; 447(3):626-33. PubMed ID: 15968547
    [Abstract] [Full Text] [Related]

  • 13. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ, Newkirk KA, Schumaker LM, Aldosari N, Rone JD, Haddad BR.
    Cancer Res; 2003 Dec 01; 63(23):8097-102. PubMed ID: 14678959
    [Abstract] [Full Text] [Related]

  • 14. Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.
    Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Okada M, Oishi T, Terakawa N.
    Cancer; 1998 Feb 15; 82(4):697-702. PubMed ID: 9477102
    [Abstract] [Full Text] [Related]

  • 15. [Expression of glutathione S-transferase pi and numerical aberration of chromosome 11 in human ovarian cancer as a prognostic indicator].
    Yokoyama Y, Fukushi Y, Kunugi T, Maruyama H, Sato S, Saito Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb 15; 48(2):118-24. PubMed ID: 8718547
    [Abstract] [Full Text] [Related]

  • 16. [An immunohistological study on expression of glutathione S-transferase pi (form) in human ovarian carcinoma].
    Satoh T, Nishida M, Miyazaki Y, Sugita M, Arisawa Y, Oki A, Nishide K, Kono K, Tsunoda H, Kubo T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Sep 15; 47(9):931-8. PubMed ID: 7594904
    [Abstract] [Full Text] [Related]

  • 17. Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer.
    Ghalia AA, Rabboh NA, el Shalakani A, Seada L, Khalifa A.
    Anticancer Res; 2000 Sep 15; 20(2B):1229-35. PubMed ID: 10810426
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical analysis of glutathione S-transferase mu expression in ovarian tumors.
    Matsumoto T, Hayase R, Kodama J, Kamimura S, Yoshinouchi M, Kudo T.
    Eur J Obstet Gynecol Reprod Biol; 1997 Jun 15; 73(2):171-6. PubMed ID: 9228500
    [Abstract] [Full Text] [Related]

  • 19. [An immunohistological study on expression of glutathione S-transferase pi (form) in human endometrial carcinoma].
    Satoh T, Nishida M, Oki A, Nishide K, Tsunoda H, Kubo T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb 15; 48(2):133-8. PubMed ID: 8718549
    [Abstract] [Full Text] [Related]

  • 20. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
    Silvestrini R, Daidone MG, Veneroni S, Benini E, Scarfone G, Zanaboni F, Villa A, Presti M, Danese S, Bolis G.
    Cancer; 1998 Jan 01; 82(1):159-67. PubMed ID: 9428493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.